Company news
Alector, Inc. news in 2021
Alector, Inc.'s news releases, calls and decks from 2021, newest first.
Alector Announces Appointment of Sara Kenkare-Mitra, Ph.D., as President and Head of Research and Development
December 14, 2021
Alector Presents Preclinical Data from AL009 Multi-Siglec Inhibitor Program at the Society for Immunotherapy of Cancer’s 36th Annual Meeting
November 11, 2021
Alector Presents Encouraging New AL001 Data from the Symptomatic FTD-GRN Cohort of INFRONT-2 Phase 2 Open-label Clinical Study
November 11, 2021
Alector Presents New Data from Multiple Pipeline Programs at 2021 CTAD Conference
November 9, 2021
Alector to Present at the Stifel 2021 Virtual Healthcare Conference
November 7, 2021
Alector Reports Third Quarter 2021 Financial Results
November 3, 2021
Alector to Present New Data from Multiple Pipeline Programs at 2021 CTAD Conference and SITC Annual Meeting
November 2, 2021
Alector Announces Appointment of Elizabeth A. Garofalo, M.D., to its Board of Directors
September 27, 2021
Alector Announces First Participant Dosed in Phase 2 Study Evaluating AL001 in Amyotrophic Lateral Sclerosis (ALS)
September 8, 2021
Alector to Present at Upcoming Virtual Healthcare Conferences
September 1, 2021
Alector Reports Second Quarter 2021 Financial Results
August 2, 2021
Alector Presents 12-Month Results from the INFRONT-2 Phase 2 Open-label Clinical Study of AL001 for the Treatment of Symptomatic Frontotemporal Dementia Patients with a Progranulin Mutation
July 28, 2021
Alector to Present New Data from Frontotemporal Dementia and Alzheimer’s Disease Programs at the 2021 Alzheimer’s Association International Conference
July 20, 2021
Alector and GSK announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases
July 1, 2021
CENTOGENE Initiates EFRONT Study to Identify Patients With Genetic Forms of Frontotemporal Dementia
June 1, 2021
Alector to Host Virtual Key Opinion Leader Event on Frontotemporal Dementia on June 11, 2021
May 25, 2021
Alector to Present at the BofA Securities 2021 Virtual Health Care Conference
May 5, 2021
Alector Reports 2021 First Quarter Financial Results and Provides Business Update
May 4, 2021
Alector to Present at Stifel’s 3rd Annual CNS Day
March 24, 2021
Alector to Present at the Barclays Global Healthcare Conference
March 3, 2021
Alector Reports 2020 Fourth Quarter and Full Year Financial Results and Provides Business Update
February 24, 2021
Alector Announces First Participant Dosed in Phase 2 Study Evaluating AL002 in Individuals with Early Alzheimer’s Disease
January 24, 2021
Alector Announces Departure of Chief Business Officer
January 19, 2021
Alector Provides 2021 Corporate Portfolio Update
January 6, 2021